The 7th National Gastric Cancer Academic Conference: Focus on translational research in gastric cancer

Chinese Journal of Cancer Research

Volumn 24, Issue 4, 2012, Pages 408-414

  Wu, Aiwen ^a   Ji, Jiafu ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA TUBULIN; CCAAT ENHANCER BINDING PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; HISTONE H3; OXALIPLATIN; PHOSPHOLIPASE A2;

ANASTOMOSIS; CANCER INVASION; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CELL ADHESION; CELL MIGRATION; CONFERENCE PAPER; CYTOGENETICS; DNA REPAIR; EARLY DIAGNOSIS; ENDOSCOPIC ECHOGRAPHY; EVIDENCE BASED MEDICINE; HISTONE ACETYLATION; HUMAN; IN VITRO STUDY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MEDICAL PRACTICE; META ANALYSIS (TOPIC); MICROMETASTASIS; OVERALL SURVIVAL; PATIENT CARE; PERITONEUM METASTASIS; PRODUCT DEVELOPMENT; STOMACH CANCER; STOMACH CARCINOMA; SYMPOSIUM; TRANSLATIONAL RESEARCH; TUMOR CLASSIFICATION; TUMOR SUPPRESSOR GENE;

EID: 84875449570     PISSN: 10009604     EISSN: 19930631     Source Type: Journal    
DOI: 10.1007/s11670-012-0282-9     Document Type: Conference Paper

References (38)

1. Jiang Y. Multidisciplinary approach for the treatment of gastric cancer. Transl Gastrointest Cancer 2012;1:175-177.
2. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006;24:2137-2150.
3. Gastric Cancer Diagnosis and Treatment Expert Panel of the Chinese Ministry of Health. Chinese guidelines for diagnosis and treatment of gastric cancer (2011 edition). Transl Gastrointest Cancer 2012;1:103-114.
4. GLOBOCAN 2008: Cancer Incidence and Mortality Worldwide (Internet). International Agenscy for Research on Cancer, World Health Organization, 2010. Available online: http://globocan.iarc.fr/
5. Wu AW, Ji JF, Yang H, et al. Long-Term Outcome of A Large Series of Gastric Cancer Patients in China. Chin J Cancer Res 2010;22:167-175.
6. Zhao G, Ford ES, Ahluwalia IB, et al. Prevalence and trends of receipt of cancer screenings among US women with diagnosed diabetes. J Gen Intern Med 2009;24:270-275.
7. Liu J, Sun LP, Gong YH, et al. Risk Factors of Precancerous Gastric Lesions in A Population at High Risk of Gastric Cancer. Chin J Cancer Res 2010;22:267-273.
8. Chuang EY. Translational Cancer Research - Message from the Editor-in-Chief. Transl Cancer Res 2012;1:1.
9. Guo YL, Lue TF. Introduction to the inaugural issue of TAU. Transl Androl Urol 2012;1:1.
10. Zhou C, Manegold C, Song Y. Something in need is something indeed. Transl Lung Cancer Res 2012;1:1-2.
11. Yang YJ. Translational Pediatrics - Message from the Editor-in-Chief. Transl Pediatr 2012;1:1.
12. Tariciotti L, Lenci I, Baiocchi L. Cholangiocarcinoma: Challenges and future needs. Transl Gastrointest Cancer 2012;1:7-9.
13. Wang YX, Ng CK. The impact of quantitative imaging in medicine and surgery: Charting our course for the future. Quant Imaging Med Surg 2011;1:1-3.
14. Hopkins S, Yang GY. FDG PET imaging in the staging and management of gastric cancer. J Gastrointest Oncol 2011;2:39-44.
15. Kang Y, Wang F, Chi Q, et al. A new subclassification of pT4 gastric cancers according to the width of serosal invasion. Transl Gastrointest Cancer 2012;1:02.
16. Liu HG. The number, the ratio of positive lymph nodes or log odds, which is the most suitable classification for gastric cancer with lymph nodes were retrieved no less than 15? Transl Gastrointest Cancer 2012;1:67.
17. Hu B, El Hajj N, Sittler S, et al. Gastric cancer: Classification, histology and application of molecular pathology. J Gastrointest Oncol 2012;3:251-261.
18. Yang D, Hendifar A, Lenz C, et al. Survival of metastatic gastric cancer: Significance of age, sex and race/ethnicity. J Gastrointest Oncol 2011;2:77-84.
19. Wu AW, Yang H, Jia YN, et al. Ratio of lymph node metastasis and lymphavascular invasion predict diseasespecific survival of proximal gastric adenocarcinoma in Chinese patients following curative resection. Transl Gastrointest Cancer 2012;1:19.
20. Xing XF, Zhang LH, Wang XH, et al. Phospholipase A2 group IIA expression correlates with prolonged survival in gastric cancer. Transl Gastrointest Cancer 2012;1:16.
21. Fan B, Zhang LH, Zhong XY, et al. S100A9-positive inflammatory cells in cancer tissues correlates with cancer stage and prognosis in patients with gastric cancer. Transl Gastrointest Cancer 2012;1:20.
22. Xue YW, Li CF. Experimental study on the effects of VEGF and EGF on biological properties of gastric cancer cells. Transl Gastrointest Cancer 2012;1:07.
23. Wang XH, Zhang LH, Xing XF, et al. Histone modification may regulate S100A6 expression in gastric cancer. Transl Gastrointest Cancer 2012;1:08.
24. Xue YW. Identification of proteins associated with lymph node metastasis of gastric cancer by comparative proteomics. Transl Gastrointest Cancer 2012;1:09.
25. Wang SF, Ba Y. Stomach cancer β-tubul in III expression in relation to sensitivity of with taxane chemotherapy. Transl Gastrointest Cancer 2012;1:69.
26. Liu R. A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Transl Gastrointest Cancer 2012;1:18.
27. Liu WT, Shi LG, Xie J, et al. Expression of cancer stem cell markers in primary lesion and lymphatic metastatic lesions of gastric carcinoma. Transl Gastrointest Cancer 2012;1:52.
28. Liu H, Ubukata H, Tabuchi T, et al. The distribution and intracellular location of Fas and Pas Ligand following gastric carcinogenesis: Fas Ligand expressing gastric carcinoma cells can inhibit local immune response. Transl Gastrointest Cancer 2012;1:66.
29. Du YX, Zhang LH, Wang XH, et al. Expression of CEBPB in human gastric carcinoma and its clinical significance. Transl Gastrointest Cancer 2012;1:03.
30. Song HJ, Wei YZ, Wang T, et al. Lumican expression in gastric cancer and its relationship with biological behavior as well as prognosis. Transl Gastrointest Cancer 2012;1:10.
31. Xu YJ, Sui H, Bai YX. Expression and clinical significance of TF and Her-2 in gastric carcinoma. Transl Gastrointest Cancer 2012;1:22.
32. Bonenkamp JJ, Hermans J, Sasako M, et al. Extended lymph-node dissection for gastric cancer. N Engl J Med 1999;340:908-914.
33. Bonenkamp JJ, Songun I, Hermans J, et al. Andomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995;345:745-748.
34. Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Cooperative Group. Br J Cancer 1999;79:1522-1530.
35. Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006;355:11-20.
36. Li ZY, Koh CE, Bu ZD, et al. Neoadjuvant chemotherapy with FOLFOX: Improved outcomes in Chinese patients with locally advanced gastric cancer. Transl Gastrointest Cancer 2012;1:14.
37. Shan F, Li ZY, Bu ZD, et al. Phase II study of oxaliplatin plus S-1 as neoadjuvant chemotherapy for advanced gastric cancer: Response and safety results. Transl Gastrointest Cancer 2012;1:17.
38. Huang JY, Sun Z, Zhu Z, et al. Efficacy and safety of intraperitoneal chemotherapy (IPC) for patients with gastric cancer: A meta-analysis. Transl Gastrointest Cancer 2012;1:42.